Taylor, Cottrill, Erickson & Associates, Inc. Abb Vie Inc. Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$359 Million
Q3 2024

A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 1,660 shares of ABBV stock, worth $298,800. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,660

Previous 1,660 -0.0%

Holding current value

$298,800

Previous $284,000 15.14%

% of portfolio

0.09%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $23,218 - $27,114	150 Added 9.93%	1,660 $284,000
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $47,946 - $54,630	-300 Reduced 16.57%	1,510 $274,000
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $13,359 - $15,465	-100 Reduced 5.24%	1,810 $269,000
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $6,625 - $8,245	-50 Reduced 2.55%	1,910 $257,000
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $3.78 Million - $4.79 Million	-35,213 Reduced 94.73%	1,960 $265,000
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $167,154 - $189,745	1,571 Added 4.41%	37,173 $4.01 Million
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $56,918 - $63,410	541 Added 1.54%	35,602 $4.01 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $110,177 - $121,291	1,077 Added 3.17%	35,061 $3.79 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $128,864 - $173,980	1,601 Added 4.94%	33,984 $3.64 Million
Q3 2020 Oct 09, 2020	BUY	$85.91 - $100.83 $22,508 - $26,417	262 Added 0.82%	32,383 $2.84 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $57,301 - $76,678	781 Added 2.49%	32,121 $3.15 Million
Q1 2020 Apr 15, 2020	SELL	$64.5 - $97.79 $115,261 - $174,750	-1,787 Reduced 5.39%	31,340 $2.39 Million
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $21,134 - $26,443	-293 Reduced 0.88%	33,127 $2.93 Million
Q3 2019 Oct 25, 2019	BUY	$62.98 - $75.72 $104,987 - $126,225	1,667 Added 5.25%	33,420 $2.53 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $262,471 - $335,500	3,995 Added 14.39%	31,753 $2.31 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $56,312 - $66,276	-730 Reduced 2.56%	27,758 $2.24 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $8,563 - $10,561	-110 Reduced 0.38%	28,488 $2.63 Million
Q3 2018 Oct 24, 2018	SELL	$88.91 - $98.84 $39,120 - $43,489	-440 Reduced 1.52%	28,598 $2.71 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $15,711 - $18,590	-175 Reduced 0.6%	29,038 $2.69 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $138,475 - $185,431	-1,505 Reduced 4.9%	29,213 $2.77 Million
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $48,899 - $53,622	-546 Reduced 1.75%	30,718 $2.97 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $2.18 Million - $2.79 Million	31,264	31,264 $2.78 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account

Taylor, Cottrill, Erickson & Associates, Inc. Abb Vie Inc. Transaction History